Sign In
Buy ALT
$2.87
-0.0300 (-1.03%)
At Close: Jun 03, 2026
Altimmune to Participate at Two Upcoming Investor Conferences
07:30am, Monday, 08'th May 2023
GAITHERSBURG, Md., May 08, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company's management team will partic
Altimmune to Report First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023
07:30am, Thursday, 04'th May 2023
GAITHERSBURG, Md., May 04, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2023 financial resu
The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy
06:26am, Friday, 28'th Apr 2023
The biotech sector is up 4.76% so far in 2023. This continues the nice run that biotech stocks had in 2022.
Top Penny Stocks To Buy Now? 10 To Watch Under $5
11:27am, Thursday, 13'th Apr 2023
10 Penny stocks under $5 to watch right now The post Top Penny Stocks To Buy Now? 10 To Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Altimmune Completes Enrollment in Phase 2 Clinical Trial of HepTcell™, an Immunotherapeutic for Chronic Hepatitis B
11:30am, Tuesday, 11'th Apr 2023 GlobeNewswire Inc.
GAITHERSBURG, Md., April 11, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company (the Company), today announced that it has completed enrollment in its
7 Analysts Have This to Say About Altimmune
03:01pm, Friday, 31'st Mar 2023 Benzinga
Analysts have provided the following ratings for Altimmune (NASDAQ:ALT) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
4
1
0
0
Last 3
7 Top Penny Stocks Under $5; Time To Buy Now?
03:28pm, Wednesday, 29'th Mar 2023 PennyStocks
Penny stocks to watch before next week.
The post 7 Top Penny Stocks Under $5; Time To Buy Now? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
7 Top Penny Stocks Under $5; Time To Buy Now?
11:28am, Wednesday, 29'th Mar 2023
Penny stocks to watch before next week. The post 7 Top Penny Stocks Under $5; Time To Buy Now?
Should You Buy Viking Therapeutics Stock After It Skyrocketed Over 60%?
09:54am, Wednesday, 29'th Mar 2023 The Motley Fool
Viking could have a strong rival to Novo Nordisk's Wegovy and Ozempic and Lilly's Mounjaro in the making.
Altimmune Appoints Former GSK Executive Catherine Angell Sohn, Pharm.D. to its Board of Directors
08:05pm, Monday, 27'th Mar 2023 GlobeNewswire Inc.
GAITHERSBURG, Md., March 27, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Catherine Angell Sohn, Pharm.D. to
4 Top Penny Stocks Under $5; Time To Buy Now?
02:31pm, Monday, 27'th Mar 2023 PennyStocks
Penny stocks to buy for under $5. Are they worth it?
The post 4 Top Penny Stocks Under $5; Time To Buy Now? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
4 Top Penny Stocks Under $5; Time To Buy Now?
10:31am, Monday, 27'th Mar 2023
Penny stocks to buy for under $5. Are they worth it?
Is Viking Therapeutics a Smart Buy on the Dip?
09:47am, Monday, 27'th Mar 2023 The Motley Fool
The stock recently fell around 25% for reasons that had nothing to do with its lead program.
Biotech Stock Roundup: ALT Obesity Data, GILD Exercises Option, INCY Drug Approval
05:51pm, Thursday, 23'rd Mar 2023 Zacks Investment Research
Incyte's (INCY) skin cancer drug approval and Altimmune's obesity data are the key highlights from the biotech sector during the past week.
Altimmune (ALT) Stock Down Despite Positive Obesity Study Data
03:18pm, Wednesday, 22'nd Mar 2023 Zacks Investment Research
Altimmune (ALT) reports positive interim analysis data from a phase II obesity study of pemvidutide. However, the stock dropped about 55% likely due to concerns regarding the high discontinuation rate
